← Back to all events
BURNSTAT News (medicine)May 25, 2026
Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study
View original article →Final score
0.00
Confidence
10/10
Amount
7M CBWD
AI justification
auto-batch-2: A==suggested, B==NEUTRAL (B conservative, A+Reconciler decided) — reversible via worker/reverse_event.py | Breakthrough gene-editing therapy shows significant cholesterol reduction, supporting public health and SDG 3.